Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Life Sciences Fund II Qp L. P. Accipiter currently holds 295,566 shares of EMAGEON INC (EMAG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Life Sciences Fund II Qp L. P. Accipiter has been a net buyer of EMAG stock. They have purchased $5.2M and sold $0 worth of shares.
Life Sciences Fund II Qp L. P. Accipiter's most recent insider trade was on Oct 24, 2008, when they purchased 6,503 shares at $2.44 per share.
Life Sciences Fund II Qp L. P. Accipiter serves as Executive at EMAGEON INC (EMAG). They have executed 35 insider transactions totaling $5.2M over their tenure at the company.
Life Sciences Fund II Qp L. P. Accipiter holds the position of Executive at EMAGEON INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Life Sciences Fund II Qp L. P. Accipiter has shown a buying trading pattern, with $5.2M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Life Sciences Fund II Qp L. P. Accipiter was on Jun 22, 2007, when they purchased $767.3K worth of (RURL) shares. This transaction involved 124,563 shares at $6.16 per share.
Life Sciences Fund II Qp L. P. Accipiter currently owns 295,566 shares of EMAGEON INC (EMAG), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Life Sciences Fund II Qp L. P. Accipiter's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Life Sciences Fund II Qp L. P. Accipiter has 35 Form 4 filings on record as an insider at EMAGEON INC.
Set alerts for Life Sciences Fund II Qp L. P. Accipiter and 40,000+ other insiders.